TEM: Revenue rose 23%, while 2026 revenue guidance increased to $1.60B–$1.605B

What happened

TEM reported third-quarter revenue of $411.5 million, up 23% from a year earlier, with growth in diagnostics and data and apps. Adjusted EBITDA, a measure of operating performance, was $25.6 million. The company raised 2026 revenue guidance to $1.60B–$1.605B, while keeping its Adjusted EBITDA guidance at about $65 million.

Confirmed

Global impact / market context

Faster revenue growth and higher 2026 revenue guidance suggest the company expects sales to expand. But unchanged Adjusted EBITDA guidance means the update does not indicate a higher expected operating-profit measure, so investors may weigh sales growth against the company’s ability to turn revenue into earnings.

Analyst inference

The reported growth came from diagnostics and data and apps, while the supplied summary gives no breakdown of their contributions or costs. That limits conclusions about which business is driving growth or whether higher sales will translate into improved profit per sale and cash available.

Analyst inference

What to watch

1. Watch whether future reports show continued growth in diagnostics and data and apps, and whether TEM provides enough detail to identify which area contributes most to revenue. Analyst inference
2. Compare later revenue results with the $1.60B–$1.605B 2026 guidance range to see whether reported sales remain consistent with the raised outlook. Analyst inference
3. Track whether Adjusted EBITDA guidance changes from about $65 million; a higher or lower outlook could signal a change in expected operating performance relative to revenue growth. Analyst inference

Evidence

• Original source link unavailable